CD2
Products Related to CD2(2)
- GC69894SiplizumabCAS: 288392-69-8Purity: >98%
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2. Siplizumab can deplete T cells, reduce T cell activation, inhibit T cell proliferation and enrich naÏve and bona fide regulatory T cells.
- GC74582NivatrotamabPurity: >99.00%
Nivatrotamab (Hu3F8-BsAb) ist ein humanisierter anti-GD2/CD3 bispezifischer Antikörper.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC69894 | Siplizumab | 288392-69-8 | >98% | |
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2. Siplizumab can deplete T cells, reduce T cell activation, inhibit T cell proliferation and enrich naÏve and bona fide regulatory T cells. | ||||
| GC74582 | Nivatrotamab | - | >99.00% | |
Nivatrotamab (Hu3F8-BsAb) ist ein humanisierter anti-GD2/CD3 bispezifischer Antikörper. | ||||